Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia)
https://doi.org/10.22416/1382-4376-2023-33-6-36-43
Abstract
Аim: analyze the results of an anonymous survey of patients with irritable bowel syndrome (IBS) to assess the degree of their satisfaction with the results of the therapy and, on this basis, determine the most optimal approaches to treatment.
Material and methods. The work was carried out in 8 subjects of the North-Western Federal District of Russia. An anonymous survey was conducted in 422 patients with mild to moderate IBS. By assessing the number of people who noted the disappearance or significant decrease in the intensity of the main manifestations of the disease one and three months after treatment, the effectiveness of complex therapy was studied. Among the patients included in the study, people with a mixed variant of IBS with a predominance of pain syndrome (n = 206) self-assessed abdominal pain using a visual pain intensity scale. The rest (n = 216) completed a self-assessment of their condition using the frequency of bowel movements and the Bristol Stool Form Scale. In each of these groups, three subgroups were formed: Subgroup 1 — treatment of patients with gastroenterological drugs; Subgroup 2 — treatment with combined pharmacotherapy (with the appointment of psychotropic drugs); Subgroup 3 — treatment with a combination of gastroenterological and psychotropic drugs and the use of non-medicinal methods of psychotherapy.
Results. The maximum difference in the subjective satisfaction of patients with their treatment was noted three months after the completion of the course of treatment in Subgroup 3 (79 % — mild IBS, 71 % — moderate IBS). Patients of Subgroup 2 after three months positively assessed the results of their treatment in 34 and 27 % of cases, respectively. In patients of Subgroup 1, the considered indicators were even less significant — 28 % (mild IBS) and 22 % (moderate IBS).
Conclusion. The treatment complex for IBS patients can be considered optimal if, in addition to symptomatic medications, appropriate psychotropic medications are necessarily included in it basing on diagnostic assessment of the psychoemotional status of a particular patient, as well as the appointment of individually selected non-medicinal methods of psychological correction in accordance with psychosomatic symptoms. Full-time cycles on psychodiagnostics and psychotherapy should be included in the educational programs of advanced training of doctors working with IBS patients.
About the Authors
A. Yu. BaranovskyRussian Federation
Andrey Yu. Baranovsky – Dr. Sci. (Med.), Professor, Head of the Scientific, Clinical and Educational Center of Gastroenterology and Hepatology, Chief freelance gastroenterologist of the North-Western Federal District of the Russian Federation.
199106, St. Petersburg, 21st Line, 8
T. V. Reshetova
Russian Federation
Tatiana V. Reshetova — Dr. Sci. (Med.), Professor of the Scientific, Clinical and Educational Center of Gastroenterology and Hepatology
199106, St. Petersburg, 21st Line, 8
I. S. Sakeyan
Russian Federation
Inga S. Sakeyan — Assistant of the Scientific, Clinical and Educational Center of Gastroenterology and Hepatology
199106, St. Petersburg, 21st Line, 8
References
1. Ivashkin V.T., Maev I.V., Shelygin Yu.A., Baranskaya E.K., Belous S.S., Belousova E.A., et al. Diagnosis and treatment of irritable bowel syndrome: Clinical recommendations of the Russian gastroenterological association and Association of coloproctologists of Russia. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(5):74–95. (In Russ.). DOI: 10.22416/1382-4376-2021-31-5-74-95
2. Larson Е., Sharma J., Bohrenc M.A., Tunçalp Ö. When the patient is the expert: measuring patient experience and satisfaction with care. Bull World Health Organ. 2019;97(8):563–9. DOI: 10.2471/BLT.18.225201
3. How to recognize and evaluate pain. 2022. URL: https://www.verywellhealth.com/pain-assessment-1131968
4. Lacy B.E., Mearin F., Chang L., Chey W.D., Lembo A.J., Simren M., et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407.E5. DOI: 10.1053/j.gastro.2016.02.031
5. Andryushchenko A.V., Drobizhev M.Yu., Dobrovolsky A.V. Comparative evaluation of CES-D, BDI and HADS(d) scales in the diagnosis of depression in general medical practice. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2003;103(3):11–8. (In Russ.).
6. Higashi A., Yashiro H., Kiyota K., Inokuchi H., Hatta H., Fujita K., et al. Validation of the hospital anxiety and depression scale in a gastro-intestinal clinic. Nihon Shokakibyo Gakkai Zasshi. 1996;93(12):884–92.
7. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70. DOI: 10.1111/j.1600-0447.1983.tb09716.x
8. Smets E.M., Garssen B., Bonke B., De Haes J.C. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25. DOI: 10.1016/0022-3999(94)00125-o
9. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol. 1957;21(4):343–9. DOI: 10.1037/h0046900
Supplementary files
Review
For citations:
Baranovsky A.Yu., Reshetova T.V., Sakeyan I.S. Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(6):36-43. https://doi.org/10.22416/1382-4376-2023-33-6-36-43